Most Read
- Qatar welcomes first batch of Doha Metro trains at Hamad Port
- Skanska invests €48m in first phase of mixed-use project in Poznan, Poland
- Goodyear using soybean oil-based rubber in tires
- DSV China: New forces - new goals
- ‘Next generation’ turbines approved for East Anglia THREE offshore windfarm
- Bayer donates proprietary data and joins forces with Quantified Planet, enabling research into biodiversity
- Toromont Industries to acquire Hewitt Equipment
- Innophos completes acquisition of Novel Ingredients
Chemicals and Pharmaceuticals
Leaps by Bayer, the investment arm of the global life sciences company Bayer, and Khloris Biosciences, a biotechnology company, have joined forces to develop novel, first-in-class anti-cancer vaccines based on human induced pluripotent stem cells.
AveXis, a Novartis company, has signed an agreement to purchase an advanced biologics therapy manufacturing campus in Longmont, Colorado.
Neste and Åbo Akademi University have signed a letter of intent on strategic cooperation, with the aim of improving the competitiveness of both parties while increasing Finnish chemical industry expertise, including such fields as chemical and process engineering, bioeconomy, and circular economy.
Fluor Corporation’s joint venture with TechnipFMC has successfully completed its engineering, procurement and construction management services scope of work on Sasol’s world-scale petrochemical complex in Westlake, Louisiana.
A consortium of world-leading companies comprising Air Liquide, Nouryon, Enerkem and the Port of Rotterdam – has announced that Shell will join as a partner in Europe’s first advanced waste-to-chemicals facility in Rotterdam, the Netherlands.
Quaker Chemical has held the grand opening of its state-of-the-art manufacturing facility in Dahej, India.
Novartis has announced that it is exercising its option to license the rights to develop and commercialise TQJ230, an investigational agent previously known as AKCEA-APO(a)-LRx, from Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals, for targeted cardiovascular therapy.
Exciting new racing talent is being fused with AkzoNobel’s latest colour technology by the McLaren Formula 1 team, who have unveiled their new car livery for the 2019 season.